Download The BC Health Authorities (BCHA) Formulary list has

BCHA Formulary Update #6
Important news about the BCHA Formulary implementation in Fraser Health
Formulary additions:
CLONIDINE powder
DIAZOXIDE oral
Formulary deletions:
Formulary changes for
the month of:
September 2012
 Formulary additions
 Formulary deletions
 Restriction changes
 Automatic Therapeutic
Interchange changes
For distribution by::
Pharmacy Department
For the information of:
BRETYLIUM
DIAZOXIDE injection
GEMFRIBROZIL
GUANETHIDINE
PINDOLOL
QUINIDINE – oral and injection
TIMOLOL oral
VERAPAMIL oral liquid
Restricted drugs - policy changes:
Drug
Restriction
SILDENAFIL
Restricted to treatment of pulmonary arterial hypertension (PAH)
nIFEdipine SR
Restricted to obstetric indications
Automatic Therapeutic Interchange changes:
Pharmacists
Nurses
Physicians
Drug ordered
Drug supplied
FENOFIBRATE regular release
As ordered
FENOFIBRATE micronized
As ordered
Action:
FENOFIBRATE microcoated 100
mg PO daily (Lipidil Supra®)
FENOFIBRATE micronized 134 mg PO daily
(Lipidil Micro®)
FENOFIBRATE microcoated 160
mg PO daily (Lipidil Supra®)
FENOFIBRATE micronized 200 mg PO daily
(Lipidil Micro®)
FENOFIBRATE nanocrystals 48 mg
PO daily (Lipidil EZ®)
FENOFIBRATE micronized 67 mg PO daily
(Lipidil Micro®)
FENOFIBRATE nanocrystals 145
mg PO daily (Lipidil EZ®)
FENOFIBRATE micronized 200 mg PO daily
(Lipidil Micro®)
Please post this notice in your
area and distribute to the
necessary patient care areas.
Ensure all staff is informed.
PLEASE POST
Contacts:
Direct general queries to
Anna Yuen, Medication
Utilization Evaluation
Pharmacist or
Aaron Tejani, Medication
Utilization Evaluation
Coordinator
Useful Links for additional information:
 Current Formulary List
 Lexi-Comp™
 Fraser Health Pharmacy Intranet – Implementation Resources
 Parenteral Drug Therapy Manual
Prepared by: Fraser Health Formulary Implementation Team
Page 1 of 1